Rivaroxaban Aminomethyl Impurity CAS 446292-10-0
New Products
Silymarin flavonolignans CAS 65666-07-1Milk Thistle Seed P.E.,65666-07-1,Silibinin ; Silybin ; silymarin group ; 2,3-Dihydro-3-(4-hydroxy-3-methoxyphenyl)-2-(hydroxymethyl)-6-(3,5,7-trihydroxy-4-oxobenzopyran-2-yl)benzodioxin,C25H22O10 […]- Magnesium ascorbyl phosphate CAS 113170-55-1Magnesium ascorbyl phosphate,113170-55-1 […]
- NGA2 N-Glycan CAS 84808-02-6Identification […]
- 4-Nitrophthalic acid CAS 610-27-54-Nitrophthalic acid,610-27-5,,5-NITROPHTHALIC ACID;AKOS B028755;4-NITROBENZENE-1,2-DICARBOXYLIC ACID;4-NITROPHTHALIC ACID;LABOTEST-BB LT00848072;RARECHEM AL BO 1138;4-nitro-2-benzenedicarboxylicacid;p-Nitro Phthalic Acid 4-Nitro Phthalic Acid […]
- alpha1, 3-fucosyltransferase ; alpha1, 3FucT CAS 37277-69-3 EC 2.4.1.65alpha1, 3-fucosyltransferase ; alpha1, 3FucT,37277-69-3,(Le(a))-dependent (alpha-3/4)-fucosyltransferase. Alpha-(1,3/1,4) fucosyltransferase Iii. Alpha-(1->4)-L-fucosyltransferase. Alpha-4-L-fucosyltransferase. Beta-acetylglucosaminylsaccharide fucosyltransferase. Blood group Lewis alpha-4-fucosyltransferase. Blood-group substance Le(a)-dependent fucosyltransferase. FucT-II. Galactoside 3(4)-L-fucosyltransferase. Guanosine diphosphofucose-beta-acetylglucosaminylsaccharide 4-alpha-L-,2.4.1.65 […]
- 2-Methyl-5-[(4-methylphenyl)amino]-1,3-benzothiazole-4,7-dione CAS 265312-55-8Identification […]
- Valerophenone CAS 1009-14-9Identification […]
- 26-Azido-3,6,9,12,15,18,21,24-octaoxahexacosan-1-amine CAS 857891-82-8Identification […]
- Molybdenum 2-ethylhexanoate(MoEHN) CAS 34041-09-3Hexanoic acid,2-ethyl-, molybdenum salt,34041-09-3,,C8H15MoO2 […]
- Fmoc-D-Phe-OH CAS 86123-10-6Fmoc-D-Phe-OH,86123-10-6,,C24H21NO4 […]
© 2026 WATSON INTERNATIONAL LIMITED. All Rights Reserved. This site and all content are protected by international Copyright laws. Third party logos and marks appearing on this website are trademarks and/or registered trademarks of their respective owners and licensors, and all rights therein and thereto are reserved to such entities.